Follow
Marta Statucka
Marta Statucka
Neuropsychologist, Toronto Western Hospital
Verified email at uhn.ca
Title
Cited by
Cited by
Year
Efficacy of social cognition remediation programs targeting facial affect recognition deficits in schizophrenia: a review and consideration of high-risk samples and sex differences
M Statucka, DJ Walder
Psychiatry Research 206 (2-3), 125-139, 2013
702013
Biological sex and menstrual cycle phase modulation of cortisol levels and psychiatric symptoms in a non-clinical sample of young adults
DJ Walder, M Statucka, MP Daly, K Axen, M Haber
Psychiatry research 197 (3), 314-321, 2012
492012
The University of California Performance Skills Assessment (UPSA) in schizophrenia
RW Heinrichs, M Statucka, J Goldberg, SMD Vaz
Schizophrenia research 88 (1-3), 135-141, 2006
442006
Origins matter: Culture impacts cognitive testing in Parkinson’s disease
M Statucka, M Cohn
Frontiers in human neuroscience 13, 269, 2019
412019
Facial affect recognition and social functioning among individuals with varying degrees of schizotypy
M Statucka, DJ Walder
Psychiatry research 256, 180-187, 2017
322017
Automated indices of clustering and switching of semantic verbal fluency in Parkinson’s disease
D Farzanfar, M Statucka, M Cohn
Journal of the International Neuropsychological Society 24 (10), 1047-1056, 2018
162018
Early neurodevelopment and psychosis risk: Role of neurohormones and biological sex in modulating genetic, prenatal and sensory processing factors in brain development.
DJ Walder, L Ospina, M Daly, M Statucka, E Raparia
Nova Biomedical Books, 2012
122012
Axial impairment following deep brain stimulation in Parkinson’s disease: A surgicogenomic approach
NP Visanji, M Ghani, E Yu, EG Kakhki, C Sato, D Moreno, T Naranian, ...
Journal of Parkinson's Disease 12 (1), 117-128, 2022
92022
Multiculturalism: a challenge for cognitive screeners in Parkinson's disease
M Statucka, K Cherian, A Fasano, RP Munhoz, M Cohn
Movement Disorders Clinical Practice 8 (5), 733-742, 2021
72021
Longitudinal cognitive follow-up in newly diagnosed glioblastoma patients treated with bevacizumab, temozolomide and hypofractionated stereotactic radiotherapy
DD Correa, R Baser, K Beal, K Sasan, DA Lisa, K Panageas, R Barradas, ...
NEURO-ONCOLOGY 13, 74-74, 2011
22011
Altruism in Parkinson’s disease.
EP Sparrow, R Leung, M Statucka, J Spaniol, M Cohn
Neuropsychology 35 (5), 547, 2021
12021
Psychotic Disorders
DJ Walder, M Statucka, M Daly, B Yaffe
Oxford University Press, 2014
12014
Multiculturalism and reported cognitive change in Parkinson’s disease
M Statucka, M Vaziri, B Iddiols, B Kaya, M Cohn
Journal of the International Neuropsychological Society 29 (10), 994-1001, 2023
2023
65 Is Basal Forebrain Volume Loss Associated with Visual Hallucinations, Mild Cognitive Impairment, or Concomitant Symptomology in Advanced Parkinson’s Disease?
SM Adamo, V Mutreja, M Statucka, B Kaya, TW Schmitz, AC Ruocco, ...
Journal of the International Neuropsychological Society 29 (s1), 575-576, 2023
2023
Do clinical neuropsychological tasks capture visuoperceptual deficits in culturally-diverse individuals with Parkinson's disease and hallucinations?
S Adamo, M Statucka, M Cohn
MOVEMENT DISORDERS 37, S528-S528, 2022
2022
Axial Impairment Following Deep Brain Stimulation in Parkinson's Disease: A Surgicogenomic Approach
N Visanji, M Ghani, E Yu, E Kakhki, C Sato, D Moreno, T Naranian, ...
MOVEMENT DISORDERS 36, S327-S327, 2021
2021
Cholinergic basal forebrain atrophy and cognitive decline in advanced Parkinson's disease
M Cohn, V Mutreja, M Statucka, T Schmitz
MOVEMENT DISORDERS 35, S165-S166, 2020
2020
Facial Affect Recognition and Social Functioning in Individuals at Risk for Schizophrenia Spectrum Disorders
M Statucka
City University of New York, 2014
2014
Poster 111 Gender Differences in Emotional Regulation and Mood in Individuals with Traumatic Brain Injury
M Statucka, J Oswald, J Cantor, T Tsaousides
Archives of Physical Medicine and Rehabilitation 94 (10), e49, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–19